Status:
COMPLETED
24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients
Lead Sponsor:
Aristotle University Of Thessaloniki
Conditions:
Primary Open Angle Glaucoma
Ocular Hypertension
Eligibility:
All Genders
29-80 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to compare the short-term mean 24-hour intraocular pressure control, 24-hour blood pressure effect and safety of Latanoprost/Timolol fixed combination given once in the ev...
Eligibility Criteria
Inclusion
- POAG
- OHT
Exclusion
- Advanced glaucoma
- Arterial Hypertension
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
End Date :
July 1 2007
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00330577
Start Date
April 1 2006
End Date
July 1 2007
Last Update
May 12 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Glaucoma Unit, A University Dept of Ophthalmology, AHEPA Hospital
Thessaloniki, Greece, 546 36